Authorizes high schools to include opioid overdose prevention and non-intravenous opioid antagonist administration as optional part of required health education courses; authorizes certain students to administer non-intravenous opioid antagonists.
S10277 would amend the Education Law to expand school health instruction on drugs to include opioid overdose prevention and the use of non-intravenous opioid antagonists, such as naloxone, at the senior high school level. The bill allows this instruction to be incorporated into required health education courses and requires high school students to demonstrate proficiency in the use of opioid overdose antagonists as a life-saving treatment. It also requires parents or guardians to be notified and gives them the right to opt their child out of the training.
The bill further creates a new Education Law section authorizing students, with written permission from both a parent and a licensed health care provider, to carry and administer a non-intravenous opioid antagonist during the school day, on school property, on school buses, and at school functions. Schools, including districts, BOCES, charter schools, and non-public schools, may provide students with medication to keep on their person and may also stock supplies on site for emergency use by trained personnel, employees, or students. The measure includes emergency-use procedures, requires contacting emergency medical services, and extends liability protection to schools and authorized individuals acting within the scope of the law absent gross negligence or willful misconduct.
The bill would modify section 804 of the Education Law and add new section 922-a, thereby expanding the legal framework for health education and emergency opioid response in schools. It would authorize, but not require, school districts and other covered schools to include opioid overdose prevention training in high school health curricula and to permit student possession and administration of naloxone or similar non-intravenous opioid antagonists. It also aligns school practice with emergency response and liability protections already recognized in education and public health law.
The bill’s structure suggests a generally supportive public-health-oriented approach, emphasizing overdose prevention, student preparedness, and emergency response in schools. Because the bill was introduced and referred to committee with no recorded votes or transcript debate in the provided materials, there is no documented floor or committee sentiment to indicate opposition or amendment activity. The overall tone of the measure is preventive and safety-focused, with built-in parental notice and opt-out provisions that may have been intended to address concerns about school-based medical training.
The main points of potential contention are the involvement of students in carrying and administering opioid antagonists, the authorization for schools to provide medication directly to students, and the extent to which schools should be able to stock and deploy naloxone-like medication. Some stakeholders may question student readiness, parental consent, privacy, or the appropriateness of making overdose response part of required health education, while others may support the measure as a practical harm-reduction tool. The bill attempts to reduce controversy by making the training optional at the school level, requiring parental notification and opt-out rights, and limiting liability protections to non-negligent conduct.